AI Therapeutics Announces Appointment of Biotechnology Industry Leader David Scheer as Chairman ...
GUILFORD, Conn., July 12, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the appointment of David Scheer as Chairman
Source: eagletribune.com